
Qoolo Unveils 'Micro-Content' Platform for Life Sciences Brands
· Solli
Solli, a media platform for the global pharma industry, wrote about Qoolo's launch and our take on medical micro-content: scientific content built for the short mobile moments healthcare professionals actually have. As Solli put it, "meeting audiences 'where they are' requires tailoring content to actual usage habits rather than simply distributing identical material across different platforms."
Thank you to Solli and its readers for taking the time to cover what we're building. Click below to read the full article.
Browse similar articles

Qoolo Named an Original Innovator of 2026 by PM360
PM360 selected Qoolo for its Original Innovators 2026 issue, in the Innovative Marketing Technology or Services category, recognizing medical micro-content infrastructure as one of the year’s most game-changing innovations in healthcare.